The Star Daily reported on December 27: Today's Star Evening News includes the following key content: National Industrial and Information Technology Work Conference: By 2025, policies for innovative development in areas such as Biomanufacturing, Quantum Industry, Embodied Intelligence, and Atomic-Level Manufacturing should be formulated; Xidiwei: The company and related personnel received a warning letter from the Guangdong Securities Regulatory Bureau; AI office enterprise Pixel Bloom completed B2 round financing led by Beijing Artificial Intelligence Industry Investment Fund.

[Hotspot Focus]

Brief news:

The National Development and Reform Commission's Low-Altitude Economic Development Department held two symposiums in a row.

Recently, responsible comrades from the National Development and Reform Commission's Low-Altitude Economic Development Department held discussions with experts in the fields of communication and navigation to exchange views on the construction of low-altitude intelligent network systems. In addition, responsible comrades from the National Development and Reform Commission's Low-Altitude Economic Development Department also held discussions with relevant ministries such as the Ministry of Natural Resources, the Ministry of Ecology and Environment, and relevant central enterprises to understand the application scenarios and development of related infrastructure for the low-altitude economy, and to discuss the orderly planning and construction of low-altitude infrastructure.

National Industrial and Information Technology Work Conference: By 2025, policies for innovative development in areas such as Biomanufacturing, Quantum Industry, Embodied Intelligence, and Atomic-Level Manufacturing should be formulated.

The National Industrial and Information Technology Working Conference was held in Beijing from the 26th to the 27th. The conference emphasized that by 2025, XINXINGCHANYE and future industries should be cultivated and strengthened. The action to cultivate new industries and create new momentum should be implemented, promoting large-scale application and demonstration of new technologies, new products, and new scenarios in the manufacturing sector. The development of intelligent connected Autos should be promoted, and the application scale of Beidou should be expanded. Low-altitude information infrastructure should be built according to local conditions. The 'Listing of Future Industry Innovation Tasks' will be carried out, and innovation and development policies will be formulated and issued in fields such as biomanufacturing, quantum industry, Asia Vets, and atomic-level manufacturing. The development of new business formats and models such as service-oriented manufacturing should be promoted, enhancing the level of industrial design.

The USA has launched a 301 investigation into policies related to China's semiconductor industry, with the Chinese business community firmly opposing this action.

On December 23, U.S. Trade Representative's Office announced a 301 investigation targeting policies related to China's semiconductor industry. At a press conference held by the China Council for the Promotion of International Trade today, a representative of the Chinese business community responded, expressing strong opposition. Spokesperson Sun Xiao stated that the Chinese business community calls on the U.S. side to faithfully adhere to WTO rules, immediately cease unilateral restrictive measures, promote industrial cooperation through dialogue and negotiation, jointly safeguard the safety and stability of the global industrial supply chain, and inject more momentum and certainty into the world economy.

Shanghai aims to establish a world-class AI industry ecosystem by the end of 2025, striving for the city's intelligent computing power to exceed 100 EFLOPS.

The Shanghai Municipal People's Government's General Office issued the "Implementation Plan for AI 'Molding Shanghai'", aiming to build a world-class AI industrial ecosystem by the end of 2025, striving for the city's intelligent computing power to exceed 100 EFLOPS, forming about 50 significantly effective industry open corpus demonstration application results, establishing 3-5 large model innovation acceleration incubators, and building a number of collaborative empowering centers and vertical model training grounds along the upstream and downstream.

The Financial Regulatory Commission states that banks and insurance institutions should establish a data security technology protection system for diverse and heterogeneous environments, including Big Data, Cloud Computing, Mobile Internet, and Internet of Things.

The National Financial Regulatory Administration issued the data security management measures for Banks and Insurance Institutions. Banks and Insurance Institutions should establish a data security technology protection system for Big Data, Cloud Computing, Penghua CSI Mobile Internet Index Fund(LOF)-A, and the Internet of Things in diverse heterogeneous environments; establish a data security technology architecture; clarify data protection strategy methods; take technical measures to ensure data security. Banks and Insurance Institutions should incorporate data security protection into the information system development life cycle framework, clearly define security protection requirements for data at the sensitive level and above, and achieve synchronized planning, construction, and use of data security protection measures and information systems.

The Shanghai Stock Exchange has announced that it will temporarily waive certain fees for the year 2025.

The Shanghai Stock Exchange has decided to reduce and waive relevant trading and service fees. 1. Waiver of the initial listing fees and annual fees for existing and new listed companies on the Shanghai market in 2025. 2. From July 1, 2025, to June 30, 2026, the trading unit usage fee will be reduced from the original 0.045 million yuan per trading unit to 0.03 million yuan annually per trading unit, with the billing period, waiver policy, and calculation method remaining unchanged. 3. Waiver of transaction handling fees for all types of bonds except for convertible bonds issued by listed companies in 2025 for cash trading (transfer), asset-backed securities trading (transfer), and repurchase agreement transactions, and no transaction handling fees for all types of bonds buyback trades in 2025. 4. Guiding subsidiaries to waive 2025 trading gateway flow fees, Shanghai Waigaoqiao Datacenter room, cabinet, and supporting resource service fees, adding waivers for technical service fees for relocated users of the Shanghai Waigaoqiao Datacenter, providing discounts on resource usage fees for Shanghai Stock Exchange's Yunzhengtong series and Xinchuang mailbox service fees. 5. Guiding subsidiaries to waive the service fees for cabinets and supporting resources at the Jinqiao Datacenter in 2025. 6. Guiding Shanghai Stock Exchange Information Network Co., Ltd. to waive 2025 fees for Shanghai Stock Exchange's e-service, e-voting service, CA certificate service, cloud roadshow service, cloud Zhengxing series service fees, and fees for public offerings and convertible bond lottery draws, providing waivers and discounts for the series of Yunzhengxin, membership data services, and market services.

South Korea's exports are expected to grow for 15 consecutive months, with Semiconductors remaining a core contributing factor.

The latest survey report shows that South Korea, known as the 'Global Economic Canary,' is expected to achieve a continuous export growth rate increase for 15 consecutive months in December. Especially under the influence of the AI boom, South Korea, home to the two storage giants SK Hynix and Samsung Electronics, is expected to continue to see significant growth in its latest semiconductor export scale, which is also the core engine driving South Korea's continuous export growth. However, economists generally believe that as market concerns about the Trump administration potentially imposing tariffs on a global scale increase, South Korea's export growth momentum may significantly slow down in the coming year.

Foxconn expects the shipment volume of AI servers in 2025 to be better than in 2024.

According to media reports citing comments from Foxconn Director Liu Yangwei, the shipment volume of AI servers in 2025 is expected to exceed that of 2024. The report states that Foxconn will maintain the original shipment plan, with the NVIDIA GB200 servers scheduled for small volume shipments in December.

Deep dive:

The National Development and Reform Commission's Low-altitude Economy Department has arrived! These two seminars indicate the future direction of work.

2024 Star medical major events: The number of listed enterprises reaches 110, with a total market value exceeding 1.1 trillion. Dividend and repurchase data hit new highs.

Gained investment from the National Manufacturing Fund! Lashi Robot initiates A-share IPO counseling.

With a valuation of 2 billion yuan, COUNTRY GARDEN is selling approximately 1.56% equity in Changxin Technology, with the buyer being Hefei State-Owned Assets.

Announcement of the Science and Technology Innovation Board

TianYue Advanced: plans to issue H Shares and list on the Hong Kong Stock Exchange.

TianYue Advanced announces that to accelerate the company's Global Strategy and Overseas Business layout, enhance the company's Overseas financing capacity, and further improve the company's capital strength and comprehensive competitiveness, the company intends to issue shares (Listed in Hong Kong) overseas and list on the Hong Kong Stock Exchange. The Board of Directors agrees to authorize the company's management to initiate the preliminary preparations for this H share listing, with the authorization valid for 12 months from the date of the Board of Directors' approval. The company plans to discuss the specific advancement of the H share listing with relevant Institutions, and the specific details of this H share listing have yet to be determined.

Xi Di Wei: The company and related personnel received a warning letter from the Guangdong Securities Regulatory Commission.

Xi Di Wei announced that the company and related personnel recently received a "Warning Letter" issued by the Guangdong Securities Regulatory Commission. Upon investigation, the company was found to have issues with inaccurate information disclosure and inappropriate use of raised funds. The Guangdong Securities Regulatory Commission has decided to impose administrative regulatory measures in the form of a warning letter against the company and Tao Hai, NAM DAVID INGYUN, and Tang Ya.

Zhongfu Shenying: the company's chairman Zhang Guoliang resigns.

Zhongfu Shenying announced that the company’s Board of Directors has recently received a resignation letter from chairman Zhang Guoliang. Due to age reasons, Zhang Guoliang has applied to resign from his positions as chairman, director, committee member of the Board of Directors, and legal representative of the company. After resigning from the above positions, Zhang Guoliang will still serve as the company's chief engineer and core technical personnel. The company will complete the re-election of directors and the election of a new chairman as soon as possible in accordance with relevant legal procedures.

Earth-Panda Advanced Magnetic Material: The company received a corrective action decision from the Anhui Securities Regulatory Bureau, and the relevant responsible persons received regulatory interview measures.

Earth-Panda Advanced Magnetic Material announced that the company and relevant responsible persons recently received a corrective action decision and regulatory interview measures issued by the Anhui Securities Regulatory Bureau. The company has issues such as non-standard management and use of raised funds, incomplete information disclosure of raised funds, and inadequate implementation of revenue recognition policies. The Anhui Securities Regulatory Bureau has decided to implement corrective administrative supervision measures for the company and regulatory interview measures for financial director Wang Ziyi and board secretary Dong Xuechun. The company stated that it will seriously learn from the lessons, enhance the standard operation level and information disclosure quality of the company, and strictly rectify according to the relevant requirements of the Anhui Securities Regulatory Bureau.

Advanced Micro-Fabrication Equipment Inc. China: Yin Zhiyao and Zhonghe Partnership plan to invest in Super Micro Company by increasing capital by 7.5 million yuan.

Advanced Micro-Fabrication Equipment Inc. China announced that Yin Zhiyao and Zhonghe Partnership plan to invest in Super Micro Company by increasing capital by 7.5 million yuan, of which Yin Zhiyao will increase capital by 2.5 million yuan and Zhonghe Partnership will increase capital by 5 million yuan.

TianYue Advanced: Terminated the issuance of Stocks to specific objects through a simplified procedure.

Tianyue Advanced announced that the company held a meeting today to review and approve the "Proposal to Terminate the Simplified Procedure for Issuing Stocks to Specific Objects" and decided to terminate the simplified procedure for issuing stocks to specific objects.

Kexing Biopharm: Termination of clinical trials for interferon α2b aerosol.

Kexing Biopharm announced that, given that the interferon α2b aerosol project has only completed clinical Phase I, which is an early clinical stage, and that conducting Phase II and III clinical studies requires significant R&D investment, combined with the status of competing products and market forecasts, the company has decided to terminate the clinical trial of this project. The termination of the clinical trial for interferon α2b aerosol will not have a significant impact on the company's current and future production operations and performance, and will not materially affect the company's investment and layout in drug R&D. The company will continue to advance the research and development work of other existing pipelines.

Huiyu Pharmaceutical: The first subject of the HY-2003 Phase I clinical trial has been dosed.

Huiyu Pharmaceutical announced that its independently developed HY-2003 is currently conducting a Phase I clinical trial to treat excessive submental fat accumulation in the population, and has successfully completed dosing for the first subject recently. HY-2003 is a Class 2.2 modified new Chemical Drug intended to improve moderate to severe contour protrusion caused by submental fat accumulation in adults.

Montage Technology: Shareholders plan to reduce their shareholding through centralized bidding.

Montage Technology announced that its shareholders, China Power Investment Corporation and its concerted actors, along with Zhuhai Rongying and its concerted actors, plan to reduce their shares in the company through a centralized bidding method. China Power Investment Corporation and its concerted actors hold a total of 6.61% of the company's shares and plan to reduce their shareholding by no more than 11,447,892 shares, accounting for 1.00% of the company's total equity. Zhuhai Rongying and its concerted actors hold a total of 9.24% of the company's shares and plan to reduce their shareholding by no more than 11,447,892 shares, also accounting for 1.00% of the company's total equity. The reduction plan will take place within three months starting from February 5, 2025, and the reduction price will be determined based on market prices. The implementation of this reduction plan will not change the fact that the company has controlling shareholders and actual controllers, nor will it adversely affect the company's governance structure and ongoing operations.

Kangxi Communication: Shareholders plan to reduce their holdings of no more than 3% of the company's shares.

Kangxi Communication announced that the shareholders who collectively hold 4.79% of the company, Yancheng Economic and Technological Development Zone Yanwu Semiconductor Industry Fund (Limited Partnership) (referred to as "Yancheng Semiconductor") and its concerted actors, Qiongcun Kangsheng, plan to reduce their holdings of the company’s shares by no more than 12.7344 million shares, accounting for 3% of the company's total share capital, through centralized bidding and/or block trading.

Ge Ke Wei: Wholly-owned subsidiary receives 60 million yuan in government subsidies.

Ge Ke Wei announced that its wholly-owned subsidiary, Ge Ke Wei Electronics (Zhejiang) Co., Ltd., has recently received a total of 60 million yuan in government subsidies, which are related to revenue.

Venture Capital Wind Vane

AI office company PixelBloom has completed Series B2 financing, led by Beijing's AI Industry Investment Fund.

Recently, AI office company PixelBloom announced the completion of Series B2 financing, led by Beijing's AI Industry Investment Fund (managed by Shunxi Fund and Qiming Venture Partners). This financing will be used for global market expansion, product line development, enhancement of AI capabilities, and other purposes.

Honghui leads investment, Tongya Technology has completed hundreds of millions in Series C financing.

Recently, Tongya Technology announced the completion of hundreds of millions of RMB in Series C financing. This round of financing was co-led by JD Capital and Honghui Fund, with Gezhizhi Capital participating, and existing shareholder Yinsan Capital investing again, with Lingjie Capital acting as the exclusive financial advisor. This financing will be used to strengthen the research and development of ultra-fine wire, expand production scale, and layout overseas markets. Tongya Technology was established in 2010 and mainly engages in the R&D, production, and sales of ultra-fine alloy conductors.

Haobo Pharma has completed $73 million in Series B financing.

Haobo Pharma announced the completion of $73 million in Series B financing. This round of financing was led by Hanking Capital, with participation from Dinghui VGC, Sherpa Investment, and a global renowned industry investment institution. Meanwhile, previous investors Qiming Venture Partners, InnoPinnacle Fund, and Yuan Sheng Venture Capital made additional investments. This financing will mainly be used to advance the clinical trials of the core innovative small nucleic acid drug AHB-137 in China and internationally, as well as for preparations for early commercialization. Additionally, the funds will support the expansion of the company's new R&D pipeline and the continuous development and construction of the team.

Hongqing Technology has completed 0.34 billion yuan in Series A1 financing.

Recently, Peking Blue Arrow Hongqing Technology Co., Ltd. announced the completion of 0.34 billion yuan in A1 round financing. This round of financing was jointly invested by Kunlun Capital, Beijing State Administration, and Guangdong Tongyu Communication Inc.

Wuxi Star Source Fund invests in Yuke Energy.

Recently, the industrial and commercial change information shows that Jiangsu Yuke Energy Technology Co., Ltd. has completed angel round financing, with Wuxi Star Source Fund as the new investor. Yuke Energy, established in 2024, is a supplier of new energy equipment, with business scope including research and development of emerging energy technologies, research and development of machinery, and manufacturing of new energy power equipment. The company is committed to providing customers with efficient and reliable new energy solutions.